西班牙学者Jim enez-Quevedo等发现,糖尿病患者,尤其在再狭窄的高危人群置入西罗莫司(雷帕霉素)洗脱支架(SES)可长期获益。已证实糖尿病患者置入SES是安全有效的,但对高危人群其长期预后仍然未知。D IABETES(D IABETES和SES)试验旨在明确与裸金属支架相比,SES的长期安全性和有 The Spanish scholar Jim enez-Quevedo et al. Found that long-term benefit is obtained in patients with diabetes, especially sirolimus-eluting stents (SES), especially in high-risk restenosis populations. It has been demonstrated that the placement of SES in patients with diabetes is safe and effective, but its long-term prognosis for high-risk groups remains unknown. The D IABETES (D IABETES and SES) trial was designed to determine the long-term safety of SES versus bare metal stents and